MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
October 09, 2015 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., Oct. 09, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
MediciNova Reports Phase IIa Clinical Study Results for MN-305, a Treatment for Insomnia
October 18, 2007 18:00 ET
|
MediciNova, Inc.
SAN DIEGO, Oct. 18, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...